VMD

VIEMED HEALTHCARE, INC.

Nasdaq· Services-Misc Health & Allied Services, NEC· Inc. A1· CIK 0001729149 Healthcare & Medical Devices

$9.73 −0.07 (−0.71%)

Oct 26 4:00 PM ET · prev $9.80

Market cap

$377.8M

Small cap

Consensus

Buy

67% Buy or better · 6 analysts

Median target

$12.50

+28% · range $11.00–14.00

Next earnings

Nov 4

in 9 days · EPS est. $0.12

1 year

+40.0%

from $6.95 · Oct 27

30 days

+6.8%

from $9.11

52-week range

$6.26–12.33

−21% from high · low Nov 6

Avg volume 20D

222.0K

shares / day

Short interest

1.57M

≈4.1% of shares · +18.5%

Days to cover

5.7

at average volume

Insider net

−$1.6M

0 buyers · 3 sellers · since Jan 29

New fund stakes

Q2 2026 13F · 0 exits

SecBot read MIXED 3 reports · 90 days

Balance 1 bearish · 1 bullish · 1 mixed oldest → newest, height = score

Avg score

·High conf. 2/3 ·Next Earnings date, Nov 4, 2026

Strongest BEARISH Michael Moore, a 5.9% beneficial owner and officer of Viemed Healthcare, has adopted a Rule 10b5-1 trading…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

R Mar 4 Viemed Healthcare reported record 2025 financial results with 21% re…
S Mar 18 to Mar 20 3 days of insider sells: $1.2M by 1 insider, avg $9.05
S Jun 24 to Jun 25 2 days of insider sells: $347.2K by 2 insiders, avg $11.57
X Jul 15 Short interest jumps 43.9% to 747.1K
R Aug 3 Viemed Healthcare reported Q2 2026 record revenue of $78.1M (+23.9%…
R Aug 20 VieMed Healthcare filed an 8-K with an investor presentation (EX-99.…
A Aug 24 Barrington Research initiates
X Aug 31 Short interest jumps 53.4% to 1.21M

Signal stack

Where each data set points today.

InsidersBEARISH

3 insiders sold $1.6M.
InstitutionsBULLISH

Q2 2026: 21 added (0 new), 8 trimmed or exited.
AnalystsBULLISH

4 of 6 rate it Buy or better. Every target is above the price.
EstimatesFALLING

Current-quarter EPS estimate $0.130 → $0.123 over 90 days.
Short sellersBUILDING

Short interest +18.5% to 1.57M shares. 5.7 days to cover, ≈4.1% of shares.
TrendUPTREND

6% above its 50-day average.

Who's buying

13F· Q2 2026

new positions

exits

Fund	Move	Shares	Value
Creative Planning	ADD	360,356	$4.1M
CITADEL ADVISORS LLC	DOUBLED	234,315	$2.7M
Walleye Capital LLC	DOUBLED	183,909	$2.1M
BANK OF AMERICA CORP /DE/	DOUBLED	158,762	$1.8M
Quantinno Capital Management LP	ADD	117,710	$1.3M
Trexquant Investment LP	TRIM	89,280	$1.0M
UBS Group AG	TRIM	78,713	$897.3K
SUSQUEHANNA INTERNATIONAL GROUP, LLP	DOUBLED	75,429	$859.9K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

6 analysts

Buy 67% rate it Buy or better

Strong Buy2Buy2Hold2Sell0Strong Sell0

12-month targets · 2 analysts

$9.73 $11.00 $12.50 $14.00

Price is below the lowest target. Median implies +28%.Targets as of Oct 26, 2026.

Recent actions

Date	Firm	Action	Rating
Aug 24, 2026	Barrington Research INITIATE	INITIATE	Outperform
Aug 6, 2026	Freedom Broker DOWNGRADE	DOWNGRADE	Hold

Insider ledger

Form 4

bought · 0 insiders

$1.6M

sold · 3 insiders

Date	Insider	Type	Value
Aug 19, 2026	Smokoff Timothy Director	EXERCISE	15,029 sh
Aug 19, 2026	Heltz Sabrina Director	EXERCISE	3,757 sh
Aug 19, 2026	Heltz Sabrina Director	EXERCISE	15,029 sh
Aug 19, 2026	Smokoff Timothy Director	EXERCISE	3,757 sh
Aug 19, 2026	Kaushal Nitin Director	EXERCISE	18,786 sh
Aug 19, 2026	Heltz Sabrina Director	TO ISSUER	$33.6K
Aug 19, 2026	Smokoff Timothy Director	TO ISSUER	$33.6K
Aug 19, 2026	Dobbs Randy E. Director	EXERCISE	4,191 sh

Earnings setup

Estimates

Nov 4

reports in 9 days

$0.12

EPS estimate, this quarter

−5%

estimate change, 90 days

Current-quarter EPS estimate

$0.130

90d

$0.130

60d

$0.123

30d

$0.123

Now

Period	EPS est.	Range	30D rev.	Revenue
Current Q	$0.12	$0.11–$0.13	+0.0%	$80.8M
Next Q	$0.15	$0.14–$0.16	+0.0%	$83.5M
Current FY	🔒 Fresh data, subscribers only
Next FY	$0.54	$0.44–$0.66	+0.0%	$353.6M